Veos is led by a senior team with deep operating experience across pharmaceuticals, agricultural biotechnology, regulatory affairs, finance, and commercial execution.
Dr. Damaj is a biotechnology operator with over two decades of experience translating early-stage research into commercial products. He holds approximately 76 US patents spanning nutraceuticals, pharmaceutical therapeutics, drug delivery, oncology, and biotechnology.
He authored one of the earliest peer-reviewed studies on hydroxytyrosol bioactivity in humans (J. Nutr., 2005), which led directly to the commercial launch of Olivenol™ with FDA GRAS status. His prior leadership roles include Innovus Pharma and NovaBay Pharmaceuticals.
Co-founder of Veos Pharmaceuticals, Samira leads finance, governance, and corporate operations across the company's four platforms.
She brings deep operational expertise in cross-border commerce, financial planning, and partnership development across European and North American markets, with formal training in business and accounting.
Dr. Mona Damaj leads scientific research for Veos's Agricultural Biotechnology platform, directing the development and field validation of crop performance and soil health technologies including BioPropello™.
She combines engineering training with doctoral-level research expertise, overseeing protocol design, field-trial methodology, and collaborations with European research institutions.
Max leads Veos's e-commerce operations across European and North American markets, with responsibility for direct-to-consumer channel performance, marketplace strategy, and digital commerce infrastructure.
His engineering background underpins a data-driven approach to product launch, listing optimization, supply chain coordination, and post-launch performance management.
Ysabell directs regulatory strategy across Veos's product portfolio, with responsibility for EU, FDA, and Health Canada filings, product registrations, GRAS submissions, and ongoing regulatory compliance.
Her RAC credential reflects formal qualification in regulatory affairs across pharmaceutical, medical device, and food/supplement frameworks — supporting Veos's multi-platform commercial expansion.